Anyone have any info on sales or prescriptions of Kynamro? I found a March 7th article on Benzinga where analysts were upgrading Aegerion, and the article mentioned they had 80 prescriptions for juxtapid 6 weeks after approval. Maybe prescriptions do not mean sales, but I haven't seen anything similar about Kynamro.
Macro, despite a scare in bird flu VICL has not been performing well. They have not beaten ISIS in the last five days, and did go down today despite the bird flu continued scare. Without your engagement as of yet, what do you have to say about that. Also, please comment without engagement on the relative strength of ISIS in the midst of this most recent market turmoil. Please get real, and please get engaged for your grandmother's sake. TIA for your valuable input. t
I don't have strawberry milkshake blood. It has been approved - enough with the scare tactics. I recall Crooke saying at a presentation or conference call that prescriptions were being written. That was weeks ago now, and I haven't seen any numbers on Kynamro. I know this board is an awful place for real information, but I know there are a few people that post here who still somewhat sensiblle.